|Home | About | Journals | Submit | Contact Us | Français|
An intervention study was conducted to determine whether discontinuing the feeding of milk replacer medicated with oxytetracycline and neomycin to preweaned calves reduced antimicrobial resistance in Salmonella, Campylobacter, and Escherichia coli bacteria. Results demonstrated that the intervention did reduce multidrug resistance in these bacteria but that other factors also influenced multidrug resistance.
Antimicrobial agents are commonly added to preweaned calf milk replacer diets to improve calf growth and decrease morbidity and mortality (1, 13, 14). However, this practice has been implicated in the development of drug resistance in bacteria (6, 11, 12) and subsequent risk of human infection with resistant zoonotic bacteria (4, 7). To address this issue, a study was conducted to determine whether discontinuing feeding of milk replacer medicated with oxytetracycline and neomycin to preweaned calves resulted in increased antimicrobial susceptibility in Salmonella, Campylobacter, and Escherichia coli bacteria isolated from calves and dairy farm environments (8).
Detailed descriptions of sample and data collection, sample processing, and laboratory methods for this study have been given elsewhere (8). Four dairy herds from Michigan and four from New York were enrolled from an earlier project (3, 5). Two large and two small herds from each state were selected, and each pair was divided into the intervention and control groups. All farms in the 3-month preintervention phase fed calves milk replacer containing oxytetracycline and neomycin without ionophores. Intervention herds then began receiving the same brand of milk replacer without antimicrobials (during the postintervention phase). Samples from all herds were obtained monthly: 3 times preintervention and 12 times postintervention.
Preweaned female dairy calves were randomly selected on the day of each farm visit, and individual 10-g fecal samples were obtained by rectal retrieval. Separate composite samples from calf and maternity pens were collected by using individual sterile gauze swabs (soaked in sterile double-strength skim milk) for four calf hutches and the corresponding maternity pen.
Commercially prepared broth microdilution antimicrobial panels (Trek Diagnostics, Inc.) were used for susceptibility testing for E. coli (CMV7CNCD), Salmonella (CMV7CNCD), and Campylobacter (CAMPY) isolates, and E. coli ATCC 25922 was used for quality control. The CMV7CNCD panel contained tetracycline, amikacin, Amoxicillin (amoxicilline)-clavulanic acid, ampicillin, ceftiofur, ceftriaxone, cephalothin (cefalotin), chloramphenicol, ciprofloxacin, cefoxitin, gentamicin, kanamycin, nalidixic acid, streptomycin, sulfamethoxazole, and trimethoprim-sulfamethoxazole, and the CAMPY panel contained azithromycin, ciprofloxacin, clindamycin, erythromycin, florfenicol, gentamicin, nalidixic acid, telithromycin, and tetracycline. Bacterial suspensions for broth microdilution were prepared and processed according to the instructions of the panel manufacturer (Trek Diagnostics, Inc.). MICs from each panel for E. coli and Salmonella were read with an autoreader, and Campylobacter panel results were read manually. The breakpoints used were those recommended by the Clinical and Laboratory Standards Institute (CLSI) and the National Antimicrobial Resistance Monitoring System 2000 annual report (16) for E. coli and Salmonella and by the National Antimicrobial Resistance Monitoring System for Campylobacter in retail meat (15). Isolates classified as intermediate or resistant were considered to be resistant for the purposes of analysis.
Differences in antimicrobial susceptibility between intervention and control herds, measured as percentages of isolates demonstrating susceptibility and numbers of isolates corresponding to specific dilutions, were calculated for E. coli, Salmonella, and Campylobacter and assessed for significance using Fisher's exact test for categorical outcomes and the Kruskal-Wallis (KW) χ2 rank-sum test for continuous outcomes. Multidrug resistance (MDR) was measured by determining the average number of agents to which fecal isolates demonstrated resistance (NAIR) at each sampling visit and the percentages of isolates demonstrating one of the following three commonly reported resistance patterns at each visit: kanamycin-streptomycin-sulfamethoxazole-tetracycline (KSSuT) resistance, ampicillin-kanamycin-streptomycin-sulfamethoxazole-tetracycline (AKSSuT) resistance, and ampicillin-chloramphenicol-streptomycin-sulfamethoxazole-tetracycline (ACSSuT) resistance. Outcomes used in analyses were the differences between each of these measures at a given visit and the corresponding measures for isolates collected during the preintervention period.
Repeated-measures generalized linear mixed models for the E. coli MDR outcomes were developed (using PROC GLIMMIX in SAS software version 9.3.1) by a hierarchical backwards model-building approach. Models were developed for both herd and isolate levels and included random-effects terms for the herd, the state and the herd size, and the month relative to the start of intervention to account for time in the models (analyses were not conducted for Salmonella and Campylobacter due to the low numbers of isolates). The main risk factor included in the models was the intervention status (association with the intervention or control group), and potential covariates included the average age of animals tested, the rates of diarrhea in preweaned calves and adult cattle, and the mortality rates in preweaned calves and adult cattle at the time of sampling; the use of oxytetracycline (yes or no) for calves and cows; and MDR of E. coli isolates from calf pens and maternity pens at the time of sampling.
Characteristics of the herds enrolled in the study have been reported elsewhere (8). Briefly, there were 126 preweaned calves, 1,120 weaned calves, and 1,517 cows at the beginning of the study. The recovery rates for E. coli, Salmonella, and Campylobacter isolates were 97, 9, and 4%, respectively, from calf fecal samples and 67, 10, and 5%, respectively, from environmental samples.
A total of 1,439 E. coli, 161 Salmonella, and 82 Campylobacter isolates were available for antimicrobial susceptibility testing. Only 9.9% of E. coli isolates, 15.5% of Salmonella isolates, and 12.2% of Campylobacter isolates were pansusceptible. Fecal samples had the highest proportions of resistant isolates (95.5, 95.6, and 90.1% of E. coli, Salmonella, and Campylobacter isolates, respectively), followed by samples from calf pens for E. coli and Salmonella isolates (81 and 40%, respectively) and those from maternity pens for E. coli and Salmonella isolates (22.2 and 9.1%, respectively). Maternity pen Campylobacter isolates had higher rates of resistance than calf pen Campylobacter isolates (75 and 60%, respectively).
MDR was common in both E. coli and Salmonella but was uncommon in Campylobacter. Overall, 88.5% of E. coli isolates, 84.5% of Salmonella isolates, and 11% of Campylobacter isolates demonstrated MDR. Differences in levels of pentaresistance (resistance to five or more agents) between groups of E. coli isolates were found, with 67.4% of isolates from control herds and 50.5% of isolates from intervention herds having pentaresistance (P, <0.01 by Fisher's exact two-tailed test; odds ratio [OR] and 95% confidence interval [95% CI] for intervention, 0.5 and 0.4 to 0.6). For Salmonella, intervention herds had statistically significantly (P < 0.0001) lower levels of pentaresistant isolates (45.4%; OR, 0.05; 95% CI, 0.03 to 0.1) than control herds (94%). The highest levels of MDR were seen in calf fecal samples (94.2% of E. coli isolates and 95.6% of Salmonella isolates were MDR). Commonly reported patterns of antimicrobial resistance (KSSuT, AKSSuT, and ACSSuT resistance) were present among E. coli and Salmonella isolates (Table (Table1).1). The most common pattern of MDR seen in Campylobacter was combined resistance to tetracycline and nalidixic acid. Isolates from diarrheal calves corresponded to higher NAIRs than nondiarrhea isolates (5.6% versus 4.9%; P = 0.04 by KW χ2 test).
After the intervention was started, isolates from intervention herds had statistically significantly greater decreases in MDR than those from control herds (P < 0.05; KW χ2 test), as indicated by the NAIRs and percentages of isolates with KSSuT and ACSSuT resistance. Time from the beginning of the intervention was associated with reducing resistance in E. coli isolates from intervention herds in the first 2 to 5 months postintervention, but this effect decreased afterwards (Fig. (Fig.1).1). MDR levels declined after the initiation of the intervention but later returned to preintervention levels. This pattern has been reported in other studies (10), and investigators found that it takes 8 years for significant shifts in the genetic composition of E. coli after starting organic practices (20), which suggests that more time is necessary to see long-term changes in cattle gut flora on the intervention farms.
Results of herd- and isolate-level (Table (Table2)2) multivariable analyses found that the intervention, oxytetracycline use, the presence of MDR in farm environments, calf age, and herd-level measures of disease and mortality were significantly associated with the NAIR and proportions of isolates with KSSuT, AKSSuT, and ACSSuT resistance. Calf age was associated with changes in MDR in fecal E. coli isolates, which agrees with results from studies indicating that resistance declines as calves age (5, 9, 20). Positive associations between MDR and morbidity have been reported in other studies (2, 17, 18, 19) and were confirmed by the positive associations found in this study between resistance and herd-level rates of diarrhea in preweaned calves and cows in the month prior to sample collection.
We demonstrated that stopping the feeding of medicated milk replacer can reduce MDR in E. coli and Salmonella isolates from calves, maternity pens, and calf pens on the farm, but additional work is needed to conclusively confirm these findings. Increasing the numbers of herds in the study and monitoring these herds for longer periods of time would be useful in determining if there are longer-term effects of discontinuing medicated milk replacers.
This work was supported by grant USDA-IREEGCP 2002-5110-01980 from the U.S. Department of Agriculture Research, Education, and Extension Competitive Grants Program.
Published ahead of print on 21 October 2009.